作者: Giuseppe Ippolito , Maria Rosaria Capobianchi , Simone Lanini , Guido Antonelli
DOI: 10.1016/J.IJANTIMICAG.2014.09.001
关键词: Immunology 、 Interferon 、 Hepatitis C virus 、 Virology 、 Antiviral therapy 、 Virological response 、 Ribavirin 、 Disease 、 Chronic hepatitis 、 Medicine
摘要: Hepatitis C virus (HCV), identified approximately 25 years ago, is recognised as the cause of several clinical conditions besides chronic hepatitis. New compounds with direct antiviral activity have recently been introduced. These drugs promise to outdo old therapies based on interferon and ribavirin both in terms improved safety virological response. In fact, these may pave way complete eradication disease. However, their actual price exceedingly high a strategy necessary guarantee wide sustainable access new therapies.